Ceforanide Production Cost Reports

The report provides a detailed analysis essential for establishing a ceforanide production plant. It encompasses all critical aspects necessary for ceforanide production, including the cost of ceforanide production, ceforanide plant cost, ceforanide production costs, and the overall ceforanide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a ceforanide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Ceforanide is a semi-synthetic antibiotic drug that is mainly used to treat bacterial infections in hospital settings. It is a second-generation cephalosporin antibiotic that is primarily utilised to fight infections caused by susceptible bacteria in different parts of the body. It finds its main application in the treatment of respiratory tract infections, skin and soft tissue infections, urinary tract infections, and bone or joint infections. It is effective against various gram-positive and gram-negative bacteria, including Escherichia coli, Klebsiella, Enterobacter, Proteus, Salmonella, Shigella, and Haemophilus species. It works by interfering with the formation of the bacterial cell wall, which helps stop the growth and spread of harmful bacteria. It is often used in hospitals as an injectable medicine for managing moderate to severe infections, including abdominal, gynaecological, and other susceptible infections. It is also used as a preventive antibiotic before certain surgical procedures, like open-heart surgery, to reduce the risk of post-operative infections.

The primary factor that drives the market for ceforanide is its demand as a broad-spectrum antibacterial for treating both gram-positive and gram-negative bacterial infections. Its application as a medication for treating respiratory infections like pneumonia, UTIs, soft tissue problems, bone and joint issues, and even endocarditis also supports its demand in the pharmaceutical industry. Its usage for surgical prophylaxis in procedures like open heart surgery, hysterectomies, and gallbladder removal to prevent post-operative infections further promotes its demand in the medical and healthcare sector. Its involvement as an injectable antibiotic in hospital settings for managing moderate to severe infections and preventing infections during surgical procedures further fuels its demand worldwide.

Moreover, technological advancements in drug formulation, rising concerns over antimicrobial resistance, supplier reliability, sustainability practices, and efficient distribution networks largely impact industrial ceforanide procurement globally. Several factors, including the cost and availability of major raw materials, regulatory compliance, and quality standards for antibiotic production, also significantly influence its procurement strategies and overall market.

Raw Material for Ceforanide Production

According to the ceforanide production plant project report, the major raw materials for ceforanide production include 7-aminocephalosporanic acid (7-ACA), 1-hydroxymethyl-5-thiol-tetrazole, 2-aminomethyl-phenylacetic acid, and N,Ndimethylbenzylamine.

Production Process of Ceforanide

The extensive ceforanide production cost report consists of the following industrial production process:

1. Production from 7-aminocephalosporanic acid (7-ACA): The production process of ceforanide begins with the reaction of 7-aminocephalosporanic acid (7-ACA) with a tetrazole thiol compound, 1-hydroxymethyl-5-thiol-tetrazole, in the presence of a Lewis acid catalyst. The reaction results in the formation of an important intermediate known as 3-MTAA-7-ACA. This intermediate serves as the foundation for building the final antibiotic structure. In the next step, the amino group of 2-aminomethyl-phenylacetic acid is temporarily protected to prevent unwanted side reactions, and it is then condensed with the 3-MTAA-7-ACA intermediate to produce crude ceforanide. The final product is purified by converting it into a dimethylbenzylamine salt, followed by crystallisation to obtain highly pure ceforanide as the desired product.

Ceforanide is a semi-synthetic, broad-spectrum, second-generation antibiotic with bactericidal activity that belongs to the class of cephalosporin. It appears as a white to pale brown solid and is hygroscopic in nature. The molecular formula of the compound is C20H21N7O6S2, and its molar mass is 519.55 g/mol. The compound has a density of approximately 1.79 g/cm³ and decomposes at its melting point, which is above 150 °C. It is only slightly soluble in aqueous base, DMSO, and methanol, and it has a pKa value of approximately 2.52. The compound has a LogP value of 0.60. It should be stored in a dark place under an inert atmosphere at temperatures below -20 °C to maintain its stability. It is marketed under the brand name Precef. The compound is classified as a sensitiser and may cause allergic skin reactions as well as allergy or asthma symptoms if inhaled. Therefore, it is recommended to wear protective clothing and avoid breathing its dust while handling.